Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
AquaBounty Technologies
AQB
$5.51M
| $617K | ﹤0.01% |
40,405
+335
| +0.8% | +$4.56K |
|
2827
Kite Realty
KRG
$5.35B
| $617K | ﹤0.01% |
29,300
-34,400
| -54% | -$701K |
|
2828
Oak Valley Bancorp
OVLY
$280M
| $617K | ﹤0.01% |
27,225
-3,931
| -13% | -$77.2K |
|
2829
Direxion Daily TSLA Bull 2X ETF
TSLL
$3.28B
| $615K | ﹤0.01% |
+98,400
| New | +$1.25M |
|
|
TECX
2830
Tectonic Therapeutic
TECX
$570M
| $615K | ﹤0.01% |
71,856
-29,989
| -29% | -$264K |
|
|
LUNA
2831
DELISTED
Luna Innovations Incorporated
LUNA
| $615K | ﹤0.01% |
70,001
-66,800
| -49% | -$423K |
|
2832
1stdibs.com
DIBS
$167M
| $614K | ﹤0.01% |
120,900
+2,400
| +2% | +$14.5K |
|
2833
Trevi Therapeutics
TRVI
$2.63B
| $614K | ﹤0.01% |
318,000
-101,187
| -24% | -$199K |
|
2834
CVRx
CVRX
$158M
| $611K | ﹤0.01% |
33,300
-30,500
| -48% | -$376K |
|
|
MPX
2835
DELISTED
Marine Products Corp
MPX
| $611K | ﹤0.01% |
51,902
-900
| -2% | -$9.47K |
|
|
GAN
2836
DELISTED
GAN Ltd
GAN
| $608K | ﹤0.01% |
405,410
-125,400
| -24% | -$211K |
|
|
CBD
2837
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $608K | ﹤0.01% |
196,100
-5,600
| -3% | -$20.4K |
|
2838
Dream Finders Homes
DFH
$1.27B
| $607K | ﹤0.01% |
+70,145
| New | +$703K |
|
2839
Neurogene
NGNE
$710M
| $607K | ﹤0.01% |
59,672
-12,431
| -17% | -$128K |
|
2840
Vanguard Morningstar Small-Cap ETF
VB
$81.3B
| $606K | ﹤0.01% |
+3,300
| New | +$612K |
|
2841
Vanguard World Funds Extended Duration ETF
EDV
$3.26B
| $605K | ﹤0.01% |
+7,300
| New | +$615K |
|
2842
Champions Oncology
CSBR
$72.1M
| $604K | ﹤0.01% |
133,891
-9,058
| -6% | -$59.2K |
|
2843
Northwest Natural Holdings
NWN
$2.14B
| $604K | ﹤0.01% |
+12,700
| New | +$595K |
|
2844
Cognex
CGNX
$11.3B
| $603K | ﹤0.01% |
12,800
-22,200
| -63% | -$1.04M |
|
2845
First Trust Preferred Securities and Income ETF
FPE
$6.34B
| $603K | ﹤0.01% |
+35,900
| New | +$602K |
|
2846
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
| $601K | ﹤0.01% |
+7,100
| New | +$587K |
|
2847
Viant Technology
DSP
$247M
| $600K | ﹤0.01% |
149,300
-9,300
| -6% | -$37.5K |
|
|
EAR
2848
DELISTED
Eargo, Inc. Common Stock
EAR
| $600K | ﹤0.01% |
52,176
-486
| -0.9% | -$6.25K |
|
2849
iShares US Financial Services ETF
IYG
$2.21B
| $599K | ﹤0.01% |
11,400
+4,500
| +65% | +$236K |
|
2850
Avantis US Equity ETF
AVUS
$14.3B
| $598K | ﹤0.01% |
8,800
+3,800
| +76% | +$260K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.